The BioProcess International (BPI) meeting in Boston has once again gathered industry leaders and innovators, marking a pivotal moment for bioprocessing advancements. This year, the event continues to showcase the latest trends and technologies shaping the future of biomanufacturing, drawing attention from regulatory, QA/QC, and CMC professionals. Notably, John Sterling, Editor in Chief of GEN, has been a consistent presence at BPI since its inception, underscoring the meeting’s significance within the sector.
During the first day of the conference, Sterling and Deputy Editor in Chief Julianna LeMieux, PhD, engaged in discussions surrounding key sessions and emerging trends. Their insights reflect a growing emphasis on innovation in bioprocessing methodologies and regulatory frameworks, which are critical for ensuring compliance and enhancing product quality. As the industry evolves, the implications of these discussions will resonate through the supply chain, influencing sourcing strategies and portfolio management for B2B professionals.
Get started today with Solo access →
